Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 321

“Parkinson’s Disease Drugs Market – Growth, Trends, and Forecast (2019-2024)”

Posted by fidest press agency su sabato, 11 Mag 2019

Parkinson’s disease drugs market is expected to witness significant growth, owing to the increasing cases of Parkinson’s disease, with the growth in aging population levels. Therefore, it may drastically result in increasing the market size during the forecast period.Pharmaceutical firms are developing new and improved therapies for Parkinson’s disease (PD), and recently, there have been some major product launches in Parkinson disease therapeutics and other assistive therapeutics.For instance, Adamas Pharmaceuticals’ amantadine extended-release capsules / Gocovri launched in Jan 2018, which was the first drug indicated for dyskinesia developed due to long-term use of levodopa.Furthermore, most of the global firms have a robust drug pipeline for the treatment of Parkinson’s disease, and as per the estimates, the forecast period may witness the launch of a few blockbuster drugs.

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: